A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Phase 3
70
about 9.3 years
0.0833333333333333+
2 sites in NC, NY
What this study is about
Researchers are testing the safety and tolerability of brivaracetam in children and adolescents with seizures. The trial will evaluate how well brivaracetam works over a long period of time.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Brivaracetam
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
brivaracetam
injection, intravenous
Primary: Incidence of treatment-emergent adverse events (TEAEs) during the study, Incidence of treatment-emergent adverse events (TEAEs) leading to discontinuation of study drug during the study, Incidence of treatment-emergent serious adverse events (SAEs) during the study
Neurology